Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic

Diabetic Retinopathy Clinical Trial

Official title:

Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT02063321
• Other study ID #: LUB012013
• Status: Enrolling by invitation
• Phase: N/A
• First received: February 11, 2014
• Last updated: February 12, 2014
• Start date: December 2012
• Est. completion date: December 2015

Study information

• Verified date: February 2014
• Source: National Institute of Endocrinology and Diabetology, Slovakia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Slovakia: State Institute for Drug Control
• Study type: Observational

Clinical Trial Summary

The aim of the study is to find out prevalence of diabetic macular edema (DME) in patients with diabetes mellitus in Slovak Republic.The outcome of the project will be epidemiology survey, prevalence of wet form of Diabetic Macular Edema in relation to duration of diabetes, type of diabetes, treatment (insulin vs. OAD or combination) etc. and identification of prognostic factors leading to development of DME.

Description:

Epidemiological study, prospective, non-interventional

1. Patient with history of diabetes ≥ 10 years or with suspected visual impairment will be enrolled and screened in NIED during hospitalization

2. Anamnesis and history of diabetes, other co-morbidities, treatment will be recorded

3. Patient undergo in NIED detailed diabetology examination and basic ophthalmology examination (best non-corrected visual acuity in ETDRS score and Amsler grid test)

4. Patient undergo in NIED examination of the back of the eye using fundus camera to take images of retina to assess long-term changes of macula, optic disc, retina vessels and surrounding tissues

5. The assessment of the ophthalmology examination will be carried out in one of two specialized reading centers - II. Eye Clinic SZU FNsP F.D.R., Banská Bystrica or OFTAL Specialized Hospital for Ophthalmology, Zvolen by Retina specialist

The process of screening will be continuous, whilst each patient will sign an informed consent.

Patients records will be stored electronically and data transmission between NIED and Reading Center will be protected using validated and secured software.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 762
• Est. completion date: December 2015
• Est. primary completion date: September 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adults =18 years treated in National Institute of Endocrinology and Diabetology

• Patients diagnosed with Diabetes mellitus type I and type 2 respectively

• Presence of Diabetes =10 years or patients with suspected visual impairment (duration of diabetes <10 years)

• Signed patient´s information and informed content

Exclusion Criteria:

• Non-compliant patients

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetic Macular Edema
• Diabetic Retinopathy
• Edema
• Macular Edema
• Retinal Diseases

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Emil Martinka	Novartis Slovakia, s.r.o.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of Diabetic Macular Edema or clinically significant Diabetic Macular Edema	Image of fundus taken in NIED securely sent via internet and electronic Clinical Report Form (eCRF) to ophthalmology reading center to assess stage and severity of potential retina damage, feedback to NIED within the stay of screened individual essential for further disease management	Patients screened during hospitalization in National Institute of Endocrinology and Diabetology (NIED), usually in 10 days	No
Secondary	Patient´s structure with DME and clinically significant DME in terms of demography and anamnesis of diabetes		Patients screened during hospitalization in NIED, usually in 10 days	No
Secondary	Range of visual deterioration and occurence of blindness in relation to duration of diabetes		Patients screened during hospitalization in NIED, usually in 10 days	No
Secondary	Prognostic factors, which determine the occurence of DME using explorative analysis		Patients screened during hospitalization in NIED, usually in 10 days	No
Secondary	Range of visual deterioration and occurence of blindness in relation to type of diabetes		Patients screened during hospitalization in NIED, usually in 10 days	No
Secondary	Range of visual deterioration and occurence of blindness in relation to general treatment (insulin vs. OAD or combination therapy)		Patients screened during hospitalization in NIED, usually in 10 days	No

External Links

•   Main Site of Principal Investigator